Diabetes Metab J.
2023 Sep;47(5):717-718. 10.4093/dmj.2023.0300.
Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65)
- Affiliations
-
- 1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea
- 2Department of Biomedical Informatics, Konyang University College of Medicine, Daejeon, Korea
- 3Division of Cardiology, Department of Internal Medicine, Yonsei University Health System, Seoul, Korea
- 4Institute of Biomedical Informatics, CHA University School of Medicine, Seongnam, Korea
- KMID: 2546130
- DOI: http://doi.org/10.4093/dmj.2023.0300
Reference
-
1. Kim HJ, Lee SJ, Sa S, Bae JH, Song G, Lee CW, et al. Safety of COVID-19 vaccines among patients with type 2 diabetes mellitus: real-world data analysis. Diabetes Metab J. 2023; 47:356–65.2. Olesen KKW, Madsen M, Gyldenkerne C, Thrane PG, Wurtz M, Thim T, et al. Diabetes mellitus is associated with increased risk of ischemic stroke in patients with and without coronary artery disease. Stroke. 2019; 50:3347–54.3. Overvad TF, Skjoth F, Lip GY, Lane DA, Albertsen IE, Rasmussen LH, et al. Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study. Stroke. 2015; 46:2168–74.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis (Diabetes Metab J 2023;47:356-65)
- Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis
- Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
- Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
- Glucose-Lowering Agents and COVID-19
